These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mycophenolate mofetil--a new immunosuppressant for organ transplantation. Med Lett Drugs Ther; 1995 Sep; 37(958):84-6. PubMed ID: 7674993 [No Abstract] [Full Text] [Related]
4. Individualization of mycophenolate mofetil dose in renal transplant recipients. van Hest RM; Hesselink DA; Vulto AG; Mathot RA; van Gelder T Expert Opin Pharmacother; 2006 Mar; 7(4):361-76. PubMed ID: 16503809 [TBL] [Abstract][Full Text] [Related]
5. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation. Behrend M Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667 [TBL] [Abstract][Full Text] [Related]
6. The efficacy of mycophenolate mofetil treatment in the prevention of acute renal rejection is related to plasma level of mycophenolic acid. Kuriata-Kordek M; Boratyńska M; Klinger M; Woźniak M; Urbaniak J; Szyber P; Patrzalek D; Tupka D Transplant Proc; 2002 Nov; 34(7):2985-7. PubMed ID: 12431678 [No Abstract] [Full Text] [Related]
8. Mycophenolate mofetil: a unique immunosuppressive agent. Hood KA; Zarembski DG Am J Health Syst Pharm; 1997 Feb; 54(3):285-94. PubMed ID: 9028422 [TBL] [Abstract][Full Text] [Related]
9. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year. Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989 [TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation. Hale MD; Nicholls AJ; Bullingham RE; Hené R; Hoitsma A; Squifflet JP; Weimar W; Vanrenterghem Y; Van de Woude FJ; Verpooten GA Clin Pharmacol Ther; 1998 Dec; 64(6):672-83. PubMed ID: 9871432 [TBL] [Abstract][Full Text] [Related]
11. Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection. Nicholls AJ Clin Biochem; 1998 Jul; 31(5):329-33. PubMed ID: 9721430 [No Abstract] [Full Text] [Related]
12. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181 [TBL] [Abstract][Full Text] [Related]